<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220401054379N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-10-13</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The effectiveness of neurodynamic techniques in diabetic peripheral neuropathy.</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of neurodynamic techniques on neuropathy severity, tibial nerve’s conduction parameters, quality of life, straight leg raising range of motion in patients with diabetic peripheral neuropathy.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/62695</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: DPN participants will be randomized to a real NDT group or a sham NDT group with a ratio of 1:1. Block-balanced randomization technique will be used for randomization with 4 character blocks containing letters A and B. Allocation instruction will be written and will be placed in sequentially numbered, opaque, sealed envelopes. The allocation sequence will be conducted by https://www.randomizer.org/. DPN participants will be blinded to allocation schedule until the end of the study. The procedure will be performed by the impartial secretary of the Baghiyatallah physical medicine and rehabilitation clinic who will not be involved with participant assessment, allocation, or treatment. The randomization schedule is known only to the first author (MA) who is the therapist of this study.
Participants will receive numbered, opaque, and sealed envelopes. The therapist who is not responsible for outcomes assessment will open these sealed envelopes and realize the participant’s treatment condition. Research team members who are responsible for data collection (SEH) and data analysis (MRP) will not be permitted to be aware of group allocation, Blinding description: This is a double-blinded trial. Participants, outcome assessor, and data analysts are all blinded regarding allocation throughout the duration of the study. Therapist will be asked not to reveal participants’ allocation status during the trial.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Diabetic peripheral neuropathy.</hc_freetext>
      <i_freetext>Intervention 1: 1. Experimental group                                                                                      a)  Real tibial nerve’s distal slider technique: This technique will be performed in the side-lying position on the intended side. Enough pillows will support the patient’s head and neck in a comfortable and neutral position and will also assure that the thoracolumbar spine is in neutral alignment. In this position, the therapist will flex the patient’s hip to 80°, and keep the knee in full extension. Therapist will move the ankle into dorsiflexion, eversion combined with toes extension, and ask the patient to extend his or her head and neck simultaneously.                                     b) Real tibial nerve’s proximal slider technique:This technique will be performed in the same position as explained for tibial nerve distal slider technique. In this position, the therapist will move the ankle toward plantarflexion, inversion combined with toes flexion and ask the patient to flex the head and neck simultaneously.                                                                 These techniques will be performed with 10 repetition in 5 sets.                  Standard basic treatment: Participants will receive TENS for 20 minutes. On of the electrodes will be placed over the popliteal fossa and the other one will be placed at the medial tarsal tunnel level. On the other hand participants will receive nerve massage for tibial nerve in transverse and longitudinal order at popliteal fossa and medial tarsal tunnel for 4 minutes. Intervention 2: 2. Control group:                                                                                               a) Sham tibial nerve’s distal slider technique: Patient will be asked to be in side-lying position as described for real slider techniques , but the therapist will move the patient’s hip toward abduction, flex the hip to 20°, and keep the knee in extended position. The sequence of sham tibial neurodynamic distal slider technique will be the same as the sequence of real tibial neurodynamic distal slider technique .                                          b) Sham tibial nerve’s proximal slider technique: Participants’ starting position will be as same as the initial position of sham tibial nerve distal slider technique. The sequence of this technique will be the same as real tibial proximal slider technique.                                                                                      These techniques will be performed with 10 repetition in 5 sets.                  Standard basic treatment: Participants will receive TENS for 20 minutes. On of the electrodes will be placed over the popliteal fossa and the other one will be placed at the medial tarsal tunnel level. On the other hand participants will receive nerve massage for tibial nerve in transverse and longitudinal order at popliteal fossa and medial tarsal tunnel for 4 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
If it is necessary, raw data of the results of the present study will be accessible for applicants.

When:
6 months after the publication date of the original article.

To whom:
Researchers, scientists, and clinicians who are interested in this field.

Conditions:
The raw data of the results of this study will be appropriate for secondary analysis in review articles, and also, can be utilized by scientists in neurodynamic or diabetic peripheral neuropathy field.

Where to obtain:
If data access was required, the individual-level dataset would be available by sending a reasonable e-mail to the first corresponding author (MRP) (pourahmadipt@gmail.com).

How to obtain:
If the request is acceptable, data will be sent by an email in one week. Request email have to sent to the first corresponding author(MRP) (pourahmadipt@gmail.com).

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyed Ebrahim Hashemi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Physical medicine and rehabilitation clinic, second floor, Baqiyatallah al-Azam Hospital</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1435915371</zip>
        <telephone>+98 21 81261</telephone>
        <email>drhashemi.pmr@gmail.com</email>
        <affiliation>Bagheiat-allah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammadreza Pourahmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of rehabilitation sciences  Department of Physical Therapy Iran university of Medical Sciences Madadkaran All., Shahnazari St., Madar Sq., Mirdamad Blvd. Tehran, Islamic Republic of Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2222 7124</telephone>
        <email>pourahmadipt@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1.	Adults (18-70 years) diagnosed with T2DM by an expert endocrinologist based on their most recent test (within the past 3 months).
2. Patients diagnosed with diabetic peripheral neuropathy based on electrodiagnostic study that was taken by an expert physiatrist.
3.	Included patients must have at least 90° hip flexion, full knee extension, and 0° dorsiflexion to 30° plantarflexion</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. Lasting low back pain, neck pain, and sciatalgia (at least for 3 days) in the last 6 months
2. History of chemotherapy or spinal surgery in the last year
3. History of peripheral nerves' injury or surgery
4. Alcohol or chemical addiction
5. Pregnancy
6. Syphilis, Guillain barre syndrome, rheumatoid arthritis
7. Infection or open wound in the lower limbs
8. Amputation proximal to the metatarsophalangeal joint
9. Complex regional pain syndrome
10. Tarsal tunnel syndrome
11. Severe diabetic peripheral neuropathy (30&lt;MDNS&lt;46)
12. Personal reluctance to paticipate in the present study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G63.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Polyneuropathy in diseases classified elsewhere</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>1. Experimental group                                                                                      a)  Real tibial nerve’s distal slider technique: This technique will be performed in the side-lying position on the intended side. Enough pillows will support the patient’s head and neck in a comfortable and neutral position and will also assure that the thoracolumbar spine is in neutral alignment. In this position, the therapist will flex the patient’s hip to 80°, and keep the knee in full extension. Therapist will move the ankle into dorsiflexion, eversion combined with toes extension, and ask the patient to extend his or her head and neck simultaneously.                                     b) Real tibial nerve’s proximal slider technique:This technique will be performed in the same position as explained for tibial nerve distal slider technique. In this position, the therapist will move the ankle toward plantarflexion, inversion combined with toes flexion and ask the patient to flex the head and neck simultaneously.                                                                 These techniques will be performed with 10 repetition in 5 sets.                  Standard basic treatment: Participants will receive TENS for 20 minutes. On of the electrodes will be placed over the popliteal fossa and the other one will be placed at the medial tarsal tunnel level. On the other hand participants will receive nerve massage for tibial nerve in transverse and longitudinal order at popliteal fossa and medial tarsal tunnel for 4 minutes.</i_keyword>
      <i_keyword>2. Control group:                                                                                               a) Sham tibial nerve’s distal slider technique: Patient will be asked to be in side-lying position as described for real slider techniques , but the therapist will move the patient’s hip toward abduction, flex the hip to 20°, and keep the knee in extended position. The sequence of sham tibial neurodynamic distal slider technique will be the same as the sequence of real tibial neurodynamic distal slider technique .                                          b) Sham tibial nerve’s proximal slider technique: Participants’ starting position will be as same as the initial position of sham tibial nerve distal slider technique. The sequence of this technique will be the same as real tibial proximal slider technique.                                                                                      These techniques will be performed with 10 repetition in 5 sets.                  Standard basic treatment: Participants will receive TENS for 20 minutes. On of the electrodes will be placed over the popliteal fossa and the other one will be placed at the medial tarsal tunnel level. On the other hand participants will receive nerve massage for tibial nerve in transverse and longitudinal order at popliteal fossa and medial tarsal tunnel for 4 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The Michigan Diabetic Neuropathy Score(MDNS). Timepoint: MDNS as the primary outcome of the present study will be evaluated before the study and at the last session. Method of measurement: The Michigan Diabetic Neuropathy Score(MDNS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Tibial nerve conduction velocity. Timepoint: Before the study and at the last session. Method of measurement: Nerve condyution study unit (Neuropack®, s1 MEB-9400, Nihon Kohden, Japan).</sec_outcome>
      <sec_outcome>Tibial nerve's distal latency. Timepoint: Before the study and at the last session. Method of measurement: Nerve condyution study unit (Neuropack®, s1 MEB-9400, Nihon Kohden, Japan) .</sec_outcome>
      <sec_outcome>Amplitude of motor nerve action potential. Timepoint: Before the study and at the last session. Method of measurement: Nerve condyution study unit (Neuropack®, s1 MEB-9400, Nihon Kohden, Japan) .</sec_outcome>
      <sec_outcome>Quality of life. Timepoint: Before the study and at the last session. Method of measurement: Persian localized version of Neuro QoL questionnaire.</sec_outcome>
      <sec_outcome>Straight leg raising range of motion. Timepoint: Before the study and at the last session. Method of measurement: Manual goniometer.</sec_outcome>
      <sec_outcome>F-wave latency. Timepoint: Before the study and at the last session. Method of measurement: Nerve condyution study unit (Neuropack®, s1 MEB-9400, Nihon Kohden, Japan) .</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-07-10</approval_date>
        <contact_name>Research Ethics Committees of Iran University of Medical Sciences</contact_name>
        <contact_address>No. 5, Farhang Street, West Sadooghi, Ashrafiesfahani street. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
